US / G
Genpact LTDG · NYSE
Genpact runs mission-critical business processes for the world's leading companies and sells them Advanced Technology Solutions—Data and AI and Agentic Solutions—to earn revenue.
- Core Business ServiceRuns enterprises' business processes, including "last mile" execution
- Data and AI SolutionsProvides technology to help clients build data and AI capabilities
- Agentic SolutionsBuilds agentic solutions that act and learn alongside humans
Summarised by AI from the 10-K, Item 1; the supporting quote was checked against the filing.
Market views this GE-spinoff labor-intensive BPO as a business AI will replace, not one that wins from it.
How rare is that fall? (US companies of the same size over ten years) →
Results over the years
| 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
|---|---|---|---|---|
| Sales | $4.4bn | $4.5bn | $4.8bn | $5.1bn |
| Operating profit | $502m | $631m | $702m | $750m |
| Net profit | $353m | $631m | $514m | $552m |
| Operating cash flow | $444m | $491m | $615m | $813m |
Fiscal years from SEC filings (10-K).
Why the market may be pricing it low
Born as GE's internal shared-services captive doing labor-intensive outsourcing, the market keeps valuing it as a legacy outsourcer.
Genpact was established more than 25 years ago as the global capability center for the General Electric CompanyBusiness
The company itself admits AI will replace part of the services it currently performs, and investors price in shrinking existing revenue.
we expect that some services that we currently perform for our clients will be replaced, in whole or in part, by AIRisk factors
Revenue concentration among top clients is rising each year, and dependence on a handful of large clients weighs on the valuation.
Top ten clients 22.4 % 23.4 %MD&A
What could close the gap
Splitting revenue disclosure into Advanced Technology Solutions vs. Core Business Services could let AI-driven growth become visible and shift perception.
we now also disaggregate our revenue as revenue from Advanced Technology Solutions and Core Business ServicesMD&A
If clients pick Genpact to guide their shift from AI experimentation to autonomous agentic operations, the market could stop viewing it as a mere subcontractor.
we believe we are well positioned to help clients move from experimentation with AI to agentic operationsBusiness
A string of executive-change filings could signal a new leadership team altering capital allocation or strategy, shifting market perception.
2026-09-08 Item 5.02,9.018-K filings
How a buyer could still lose (value trap)
With debt of $1,180 million against cash of only $517 million, if AI-driven demand erosion hits this labor-intensive model, profitability could shrink while leverage remains.
Based on the figures below
Despite a Piotroski score of 7, ROA and the current ratio have not improved year-over-year, so the apparent cheapness may reflect an unfinished balance-sheet repair rather than a bargain.
Based on the figures below
Drafted by AI on 1 Oct 2026 from the figures on this page and excerpts of the filing only (no web search). Each point's quote was checked by machine against the filing text; points whose quote could not be found are not shown. These are hypotheses, not findings. Latest 10-K (SEC)
Financial quality (Piotroski F-score)
- ✓Profitable (ROA > 0)
- ✓Positive operating cash flow
- ✗ROA up on last year
- ✓Cash flow exceeds net profit
- ✓Leverage down on last year
- ✗Current ratio up on last year
- ✓No new shares issued
- ✓Gross margin up on last year
- ✓Asset turnover up on last year
Scored out of the checks with data, scaled to 9. Compares the latest year with the year before.
Figures
- Sales
- $5.3bn
- Operating profit
- $798m
- Net profit
- $588m
- Operating cash flow
- $429m
- Cash
- $499m
- Debt
- $1.2bn
- Equity
- $2.7bn
Latest twelve months to 2026-09-30; F-score for the fiscal year to 2025-12-31
This site ranks companies whose share price is low relative to their profits, using public filings and market prices, and has AI draft hypotheses on why they are cheap from those filings. The hypotheses are unverified. Nothing here is a price forecast or a recommendation to buy or sell. Not investment advice.
Updated 10 Nov 2026 08:40 JST